Aquestive Therapeutics, Inc. (AQST)
3.955
+0.12
(+3.26%)
USD |
NASDAQ |
Feb 19, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics EPS Diluted (Quarterly) : -0.1397 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.747 |
| Merck & Co., Inc. | 1.191 |
| Beta Bionics, Inc. | -0.3047 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.45M |
| Revenue (Quarterly) | 12.81M |
| Total Expenses (Quarterly) | 28.25M |
| Enterprise Value | 467.07M |
| Gross Profit Margin (Quarterly) | 64.82% |
| Profit Margin (Quarterly) | -120.6% |
| Earnings Yield | -17.78% |
| Normalized Earnings Yield | -17.78 |